Everyone keeps talking about how the industry is on the brink of great change….it’s the death of the blockbuster….the birth of…what?  The niche-buster? Personalized medicine? 

Just keeping up and fire-fighting may be difficult enough so it is tempting to be like Scarlet O’Hara, as in “we’ll just deal with those issues tomorrow.” 

At the Bioprocess International Conference in Raleigh this week, keynote speaker Paul McKenzie showed that he is taking some of the thinking that he had brought to BMS (read on for a 2007 cover story interview touching on this work) to Centocor, only now he is moving the effort from the lab to the plant level, rather than the other way around.